| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5875183 | Journal of Stroke and Cerebrovascular Diseases | 2014 | 6 Pages |
Abstract
Analysis of the NCB supports that rivaroxaban therapy provides clinical benefit for Japanese patients with AF.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Shinichiro MD, PhD, Masatsugu MD, PhD, Masayasu MD, PhD, Norio MD, PhD, Shin-ichi MD, Shinya MD, PhD, Tohru MD, PhD, Yukihiro MD, PhD, Mariko MD, PhD, Masaharu MSc, Hitoshi PhD, Kazuma MD, PhD, Satoshi MD, PhD, Masahiro BSc,